Literature DB >> 27091599

Asthma, hay fever, and food allergy are associated with caregiver-reported speech disorders in US children.

Mark A Strom1, Jonathan I Silverberg2,3.   

Abstract

BACKGROUND: Children with asthma, hay fever, and food allergy may have several factors that increase their risk of speech disorder, including allergic inflammation, ADD/ADHD, and sleep disturbance. However, few studies have examined a relationship between asthma, allergic disease, and speech disorder. We sought to determine whether asthma, hay fever, and food allergy are associated with speech disorder in children and whether disease severity, sleep disturbance, or ADD/ADHD modified such associations.
METHODS: We analyzed cross-sectional data on 337,285 children aged 2-17 years from 19 US population-based studies, including the 1997-2013 National Health Interview Survey and the 2003/4 and 2007/8 National Survey of Children's Health.
RESULTS: In multivariate models, controlling for age, demographic factors, healthcare utilization, and history of eczema, lifetime history of asthma (odds ratio [95% confidence interval]: 1.18 [1.04-1.34], p = 0.01), and one-year history of hay fever (1.44 [1.28-1.62], p < 0.0001) and food allergy (1.35 [1.13-1.62], p = 0.001) were associated with increased odds of speech disorder. Children with current (1.37 [1.15-1.59] p = 0.0003) but not past (p = 0.06) asthma had increased risk of speech disorder. In one study that assessed caregiver-reported asthma severity, mild (1.58 [1.20-2.08], p = 0.001) and moderate (2.99 [1.54-3.41], p < 0.0001) asthma were associated with increased odds of speech disorder; however, severe asthma was associated with the highest odds of speech disorder (5.70 [2.36-13.78], p = 0.0001).
CONCLUSION: Childhood asthma, hay fever, and food allergy are associated with increased risk of speech disorder. Future prospective studies are needed to characterize the associations.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ADD/ADHD; allergy; asthma; atopic disease; food allergy; hay fever; sleep disturbance; speech delay; speech disorder

Mesh:

Year:  2016        PMID: 27091599      PMCID: PMC5216174          DOI: 10.1111/pai.12580

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  36 in total

1.  Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults.

Authors:  M Kilpeläinen; E O Terho; H Helenius; M Koskenvuo
Journal:  Allergy       Date:  2001-05       Impact factor: 13.146

2.  The impact of speech therapy on asthma and allergic rhinitis control in mouth breathing children and adolescents.

Authors:  Silvia M A Campanha; Maria J F Fontes; Paulo A M Camargos; Lincoln M S Freire
Journal:  J Pediatr (Rio J)       Date:  2010-05-06       Impact factor: 2.197

3.  Childhood speech disorders: reported prevalence, comorbidity and socioeconomic profile.

Authors:  D Keating; G Turrell; A Ozanne
Journal:  J Paediatr Child Health       Date:  2001-10       Impact factor: 1.954

4.  Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation.

Authors:  Melissa A Rosenkranz; William W Busse; Tom Johnstone; Cheri A Swenson; Gina M Crisafi; Maryjo M Jackson; Jos A Bosch; John F Sheridan; Richard J Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

Review 5.  Passage of cytokines across the blood-brain barrier.

Authors:  W A Banks; A J Kastin; R D Broadwell
Journal:  Neuroimmunomodulation       Date:  1995 Jul-Aug       Impact factor: 2.492

6.  Subjective and objective evaluation of voice quality in patients with asthma.

Authors:  Muzeyyen Dogan; Emel Eryuksel; Ismail Kocak; Turgay Celikel; Mehmet Ali Sehitoglu
Journal:  J Voice       Date:  2006-02-28       Impact factor: 2.009

Review 7.  Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review.

Authors:  J Schmitt; A Buske-Kirschbaum; V Roessner
Journal:  Allergy       Date:  2010-08-17       Impact factor: 13.146

8.  Relationship between pulmonary test variables and asthma and wheezing: a validation of self-report of asthma.

Authors:  A Senthilselvan; J A Dosman; Y Chen
Journal:  J Asthma       Date:  1993       Impact factor: 2.515

9.  Otitis media with effusion during the first three years of life and development of speech and language.

Authors:  D W Teele; J O Klein; B A Rosner
Journal:  Pediatrics       Date:  1984-08       Impact factor: 7.124

10.  Sleep quality in asthma: results of a large prospective clinical trial.

Authors:  John G Mastronarde; Robert A Wise; David M Shade; Christopher O Olopade; Steven M Scharf
Journal:  J Asthma       Date:  2008-04       Impact factor: 2.515

View more
  4 in total

1.  Identifying developmental stuttering and associated comorbidities in electronic health records and creating a phenome risk classifier.

Authors:  Dillon G Pruett; Douglas M Shaw; Hung-Hsin Chen; Lauren E Petty; Hannah G Polikowsky; Shelly Jo Kraft; Robin M Jones; Jennifer E Below
Journal:  J Fluency Disord       Date:  2021-04-15       Impact factor: 2.538

2.  Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data.

Authors:  Martin Sommer; Andrea Waltersbacher; Andreas Schlotmann; Helmut Schröder; Adam Strzelczyk
Journal:  Front Hum Neurosci       Date:  2021-04-12       Impact factor: 3.169

Review 3.  Paediatric asthma and non-allergic comorbidities: A review of current risk and proposed mechanisms.

Authors:  Bronwyn K Brew; Emma Caffrey Osvald; Tong Gong; Anna M Hedman; Kirsten Holmberg; Henrik Larsson; Jonas F Ludvigsson; Mwenya Mubanga; Awad I Smew; Catarina Almqvist
Journal:  Clin Exp Allergy       Date:  2022-07-28       Impact factor: 5.401

4.  Subtypes of stuttering determined by latent class analysis in two Swiss epidemiological surveys.

Authors:  Vladeta Ajdacic-Gross; Laura Bechtiger; Stephanie Rodgers; Mario Müller; Wolfram Kawohl; Roland von Känel; Margot Mutsch; Wulf Rössler; Erich Seifritz; Enrique Castelao; Marie-Pierre F Strippoli; Caroline Vandeleur; Martin Preisig; Peter Howell
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.